> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 7 NADAs Withdrawn Over Reporting Requirements
- URL: https://www.fdaweb.com/7-nadas-withdrawn-over-reporting-requirements/
- Published: 2021-02-25T12:00:00.000Z
- Updated: 2026-09-14T16:48:37.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148749

*Federal Register* notice: FDA is amending its animal drug regulations to reflect the withdrawal of approval of seven new animal drug applications for lack of compliance with regulation-reporting requirements. They are: 

- Walco International’s Cuprate (cupric glycinate)
- Oxis International’s Palosein (orgotein)
- ConAgra Pet Products’ Sergeants Sure Shot (n-butyl chloride)
- ConAgra Pet Products’ Sergeants Puppy Worm Capsules (n-butyl chloride)
- Premo Pharmaceutical Laboratories’ tetracycline HCl tablets
- RSR Laboratories’ Elite (dichlorophene and toluene) Dog and Cat Wormer.
- Alaco’s Bapten for Injection (+-aminopropionitrile fumarate)

To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-02-23/pdf/2021-03251.pdf?ref=fdaweb.com).